Shanghai Shyndec Pharmaceutical Co., Ltd. Class ASSE: 600420

Announcement on the Wholly-owned Subsidiary Obtaining the Approval Notice for Drug Supplementary Application

· Issued by Shanghai Shyndec Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Wholly-owned Subsidiary Obtaining the Approval Notice for Drug Supplementary Application

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment